|
NCCN Guidelines® Insights - Cervical Cancer, Version 1.2020 |
1.00 |
06/10/2020 - 12:00am to 06/10/2021 - 12:00am |
|
NCCN 2020 Nursing Program: Survivorship Needs of Patients Living with Chronic Metastatic Disease |
1.00 |
04/27/2020 - 12:00am to 08/14/2020 - 12:00am |
|
NCCN 2020 Nursing Program: Oral Chemotherapy and Compliance |
1.00 |
06/22/2020 - 12:00am to 09/27/2020 - 12:00am |
|
NCCN 2020 Nursing Program: Improving Efficiency and the Patient Experience in the Ambulatory Setting |
1.00 |
05/05/2020 - 12:00am to 08/14/2020 - 12:00am |
|
NCCN 2020 Nursing Program: Evolution of Immunotherapy and Management of Complex Toxicities |
1.00 |
04/27/2020 - 12:00am to 08/14/2020 - 12:00am |
|
NCCN 2020 Nursing Program: A Practical Approach to the Diagnosis and Treatment of Anemia in Cancer Patients |
1.00 |
04/27/2020 - 12:00am to 08/14/2020 - 12:00am |
|
Multidisciplinary Management of Advanced Kidney Cancer |
0.75 |
05/15/2020 - 12:00am to 03/01/2021 - 12:00am |
|
Monthly Oncology Tumor Boards: A Multidisciplinary Approach to Individualized Patient Care - Head and Neck Cancer |
1.00 |
06/17/2020 - 12:00am to 10/25/2020 - 12:00am |
|
Monthly Oncology Tumor Boards: A Multidisciplinary Approach to Individualized Patient Care - Breast Cancer |
1.00 |
05/26/2020 - 12:00am to 09/02/2020 - 12:00am |
|
Monthly Oncology Tumor Boards: A Multidisciplinary Approach to Individualized Patient Care - Bladder Cancer |
1.00 |
07/10/2020 - 12:00am to 12/06/2020 - 12:00am |
|
Molecular Testing Updates and Impact for Clinical Practice |
0.75 |
05/08/2020 - 12:00am to 03/01/2021 - 12:00am |
|
Management of Toxicities with Targeted Therapies for Breast Cancer |
0.36 |
03/15/2020 - 12:00am to 03/15/2021 - 12:00am |
|
Management of Toxicities Related to CAR T-Cell Therapy |
0.62 |
11/01/2019 - 12:00am to 10/31/2020 - 12:00am |
|
Management of Rare Breast Cancers |
0.50 |
03/15/2020 - 12:00am to 03/15/2021 - 12:00am |
|
Management of Metastatic Breast Cancer, Including SABCS Updates |
0.75 |
03/15/2020 - 12:00am to 03/15/2021 - 12:00am |
Facebook
Twitter
LinkedIn
Forward